Have a personal or library account? Click to login
Assessment of chemical-shift and diffusion-weighted magnetic resonance imaging in differentiating malignant and benign vertebral lesions in oncologic patients. A single institution experience Cover

Assessment of chemical-shift and diffusion-weighted magnetic resonance imaging in differentiating malignant and benign vertebral lesions in oncologic patients. A single institution experience

Open Access
|Oct 2024

Figures & Tables

FIGURE 1.

A 50-year-old woman with breast cancer and focal benign vertebral bone marrow lesion (VBML) (arrows). A round-shaped, abnormal signal intensity change in the bone marrow is evident in the L1 body on sagittal T1-weighted (A), short tau inversion recovery (STIR), (B), contrast-enhanced fat- satureted T1-weighted (C) in-phase T1-weighted (D), out-of-phase T1-weighted (E) images. Apparent diffusion coefficient (ADC) (F) value is 1.74 x 10−3 mm2/s. The signal intensity ratio (SIR) value is calculated as 0.8 and is consistent with benignity. Standardized Uptake Value (SUV) on PET scan excluded malignancy. After one year of follow-up, the lesion STIR/postcontrast hyperintensity almost disappeared.
A 50-year-old woman with breast cancer and focal benign vertebral bone marrow lesion (VBML) (arrows). A round-shaped, abnormal signal intensity change in the bone marrow is evident in the L1 body on sagittal T1-weighted (A), short tau inversion recovery (STIR), (B), contrast-enhanced fat- satureted T1-weighted (C) in-phase T1-weighted (D), out-of-phase T1-weighted (E) images. Apparent diffusion coefficient (ADC) (F) value is 1.74 x 10−3 mm2/s. The signal intensity ratio (SIR) value is calculated as 0.8 and is consistent with benignity. Standardized Uptake Value (SUV) on PET scan excluded malignancy. After one year of follow-up, the lesion STIR/postcontrast hyperintensity almost disappeared.

FIGURE 2.

A 75-year-old woman with breast cancer and five focal malignant vertebral bone marrow lesions (VBMLs), the most prominent in the L1 body (arrows) which we chose to analyze. Abnormal signal intensity change is evident on sagittal T1-weighted (A), short tau inversion recovery (STIR), (B), contrast-enhanced fat-satureted T1-weighted (C) in-phase T1-weighted (D), and out-of-phase T1-weighted (E). Apparent diffusion coefficient (ADC) (F) value is 0.99 x 10−3 mm2/s. The signal intensity ratio (SIR) value is calculated as 1.07. which indicates the malignant lesion. Sci suggested malignant lesions.
A 75-year-old woman with breast cancer and five focal malignant vertebral bone marrow lesions (VBMLs), the most prominent in the L1 body (arrows) which we chose to analyze. Abnormal signal intensity change is evident on sagittal T1-weighted (A), short tau inversion recovery (STIR), (B), contrast-enhanced fat-satureted T1-weighted (C) in-phase T1-weighted (D), and out-of-phase T1-weighted (E). Apparent diffusion coefficient (ADC) (F) value is 0.99 x 10−3 mm2/s. The signal intensity ratio (SIR) value is calculated as 1.07. which indicates the malignant lesion. Sci suggested malignant lesions.

FIGURE 3.

The receiver operating characteristic (ROC) curves of the apparent diffusion coefficient (ADC) (red line), signal intensity ratio (SIR) (green line), and combined SIR and ADC (blue line). The ROC curves show that the combined SIR and ADC have the highest AUC for differentiating benign from malignant vertebral bone marrow lesions (VBMLs), followed by the SIR and ADC.
The receiver operating characteristic (ROC) curves of the apparent diffusion coefficient (ADC) (red line), signal intensity ratio (SIR) (green line), and combined SIR and ADC (blue line). The ROC curves show that the combined SIR and ADC have the highest AUC for differentiating benign from malignant vertebral bone marrow lesions (VBMLs), followed by the SIR and ADC.

Diagnostic performance of the signal intensity ratio (SIR), apparent diffusion coefficient (ADC), and combination (SIR, ADC) for differentiating benign from malignant vertebral bone marrow lesions (VBMLs)

ParametersAUC (95% CI)Standard errorpCut-offSensitivity (%)Specificity (%)
SIR0.953 (0.886–0.987)0.029< 0.001> 0.8293.688.5
ADC0.894 (0.769–0.965)0.077< 0.001≤ 1.5788.292.3
Combination (SIR, ADC)0.988 (0.872–1.000)0.014< 0.001> 0.19100.090.9

The studies of diffusion-weighted imaging in the differentiation of bone marrow lesions

AuthorsNo. of lesionsClinical featuresTechnical parameters No. of image planesTechnical parameters b values (s/mm2)ADC cut-off values (× 10−3 mm2/s)
Park et al.986Traumatic CFs vs. tumor infiltration with/without malignant CFsSingle shot SE EPI0, 400, 10001.14
Kwack et al.10126Focal benign lesion vs. metastasesSingle-shot echo-planar0, 8000.995
Geith et al.1246Osteoporotic vs. malignant CFsSingle shot TSE100, 250, 4001.7
Park et al.2358Hyperplastic hematopoietic BM vs. malignant BM lesionsSingle shot SE EPI0, 8000.695
Schmeel et al.2789Benign (traumatic, inflammatory, and primary) vs. malignant (metastatic and hematologic)Single-shot spin-echo echo-planar with multislice short TI inversion recovery fat suppression0, 8001.08
Pozzi et al.29116Benign primary tumors vs. bone metastases vs. malignant primary tumorsSpin-echo echo-planar technique0, 10000.952 (benign vs. malignant tumors)
Hajalioghli et al.3023Atypical hemangiomas and metastasesSpin-echo single-shot echo-planar with fat suppression50, 4000.958
Lee et al.3151Schmorl nodes vs. bone metastasesSingle-shot (FOCUS, GE Healthcare)0, 400, 10001.028
DOI: https://doi.org/10.2478/raon-2024-0049 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 527 - 534
Submitted on: Apr 11, 2024
|
Accepted on: Jul 25, 2024
|
Published on: Oct 4, 2024
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2024 Marija B Mijaljevic, Zorica C Milosevic, Slobodan Đ Lavrnic, Zorica M Jokovic, Danica I Ninkovic, Radoje M Tubic, Rajna R Jankovic, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.